The management of androgenetic alopecia (AGA) has been materially altered b
y the availability of the 5 alpha -reductase type 2 inhibitor, finasteride.
Nevertheless, this agent is only one component of successful management, a
nd an understanding of the role of camouflage agents, surgical options, and
other medical treatments is important. Because no treatment completely rev
erses baldness, it is important to communicate the limitations of each moda
lity to the patient so that he has appropriate expectations of the outcome
of any intervention. Patient counseling and support are also often relevant
.